相关实验视频
Updated: Sep 18, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
304
肺纤维化中的上皮细胞功能障碍:机制,相互作用和新兴的治疗点
1Department of Physiology, School of Medicine, Southeast University, Nanjing 210009, China.
Pharmaceuticals (Basel, Switzerland)
|June 27, 2025
概括
肺纤维化 (PF) 涉及上皮细胞功能障碍和过度的细胞外基质 (ECM) 沉积. 准上皮细胞通路为这种渐进的肺病提供了新的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 肺纤维化 (PF) 是一种致命的肺病,其特征是慢性上皮损伤和细胞外基质 (ECM) 沉积.
- 表皮细胞功能障碍,包括表皮-介质细胞过渡 (EMT),氧化应激和改变的免疫相互作用,是PF病变的核心.
- 单细胞研究揭示了2型膜细胞 (AT2) 中的亲纤维细胞亚群.
研究的目的:
- 审查肺纤维化进展中的表皮功能障碍背后的分子机制.
- 要突出关键的调节通路 (TGF-β,Wnt,Notch,miRNA) 参与纤维化.
- 探索临床转化新兴的上皮向治疗方法.
主要方法:
- 文献综述侧重于肺纤维化中的分子机制和治疗策略.
- 信号通路 (TGF-β,Wnt,Notch) 和miRNA网络的分析.
- 在PF期间检查上皮细胞的代谢和表观遗传变化.
主要成果:
- 表皮细胞功能障碍,以EMT,氧化应激和免疫失调为特征,驱动PF.
- 不同的AT2细胞亚群表现出亲纤维细胞特征.
- 表皮细胞的代谢和表观遗传变化呈现出治疗点.
结论:
- 了解表皮功能障碍机制对于开发抗纤维化策略至关重要.
- 针对关键信号通路和分子网络,为PF的精准医学提供了潜力.
- 新兴疗法,包括FDA批准的药物和新型抑制剂,显示出临床转化有前途.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20COPD: Pathogenesis and Clinical Features
535
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
535
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:23Cystic Fibrosis: Pathogenesis
369
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
369
01:24Cystic Fibrosis: Management
228
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
228
01:09Introduction to Fibroblasts
3.2K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.2K